SCHEMBL8893462

SCHEMBL8893462

[CH2]C(C)(Cc1c[nH]c2ccccc12)C(=O)NC(CO)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.50
USP2 O75604 2/20 0.48
TACR1 P25103 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ECE1 P42892 1/20 0.47
CTSL P07711 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9293690 0.88 ACE (0.48) ACEUSP2TACR1KDM4EMEN1
SCHEMBL27330226 0.88 ACE (0.50) ACEUSP2TACR1KDM4EMEN1
SCHEMBL8829880 0.88 ACE (0.50) ACEUSP2TACR1KDM4EMEN1
SCHEMBL8829871 0.86 TACR1 (0.58) TACR1
SCHEMBL8829867 0.86 TACR1 (0.58) TACR1
SCHEMBL6888621 0.86 TACR1 (0.58) TACR1
SCHEMBL6888466 0.83 USP2 (0.47) ACEUSP2TACR1KDM4EMEN1
SCHEMBL8700148 0.82 ACE (0.51) ACEUSP2TACR1KDM4EMEN1
SCHEMBL9613706 0.81 CCKBR (0.56) ACETACR1KDM4EMEN1ALDH1A1
SCHEMBL8894490 0.80 KDM4E (0.50) ACETACR1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593967-A Cholecystokinin antagonists, their preparation and therapeutic use WARNER-LAMBERT COMPANY (US) 1997-01-14 US disclosed
WO-1992004045-A1 NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE WARNER-LAMBERT COMPANY (US) 1992-03-19 WO disclosed